Alclometasone Dipropionate

阿氯米松

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAlclometasone Dipropionate
Drug Alias Name二丙酸阿氯米松alclometasonumalclometasona双丙酸阿氯米松二丙酸别氯地米松 +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsHypersensitivityPsoriasisPruritus +[6] 
Global Approved IndicationsPsoriasisPruritusEczema +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1982/12/14
Country/TerritoryUnited StatesUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShionogi Pharma Co LtdAspire Pharma LtdChongqing Huapont Pharmaceutical Co Ltd
Inactive CompaniesGlaxosmithkline PlcFougera Pharmaceuticals Inc
Active IndicationsPsoriasisPruritusEczema +[4] 
Inactive IndicationsHypersensitivitySkin Diseases

Other Information

ATC CodeD07AB10S01BA10
Related LinksWikipediaDrugBankKEGG